International Biotechnology Trust (IBT) 31 Aug 2002 Page 13
International Biotechnology Trust plc
Unaudited Preliminary Results
Unaudited Statement of Total Return (incorporating the Revenue Account)
For the year end 31 August 2002
For the year end 31 August 2001
Revenue
Capital
Total
Revenue Capital
Total
£'000
£'000
£'000
£'000 £'000
£'000
Realised (losses)/
gains on investments
(16,865)
(16,865)
50,942
50,942
Performance fee
and termination costs
(2,160)
(2,160)
Increase in unrealised
depreciation on
investments
(32,667)
(32,667)
(173,782)
(173,782)
Exchange loss on
currency balances
(28)
(28)
(1,359)
(1,359)
Income
278
278
2,700
2,700
Management fees
(804)
(804)
(2,171)
(2,171)
Administrative
expenses
(758)
(758)
(1,690)
(1,690)
Net deficit on ordinary
activities before
finance costs and
taxation
(1,284)
(49,560)
(50,844)
(1,161) (126,359)
(127,520)
Interest payable and
similar charges
(15)
(15)
Net deficit on ordinary
activities before
taxation
(1,284)
(49,560)
(50,844)
(1,176) (126,359)
(127,535)
Tax on ordinary
activities
Net deficit on ordinary
activities after
taxation
(1,284)
(49,560)
(50,844)
(1,176) (126,359)
(127,535)
Transfer from
reserves
(1,284)
(49,560)
(50,844)
(1,176) (126,359)
(127,535)
Deficit per share
(2.64)p
(101.94)p
(104.58)p
(1.86)p (199.60)p
(201.46)p
The revenue column of this statement is the profit and loss account of the Company.
All revenue and capital items in the above statement derive from continuing operations.
